Report Library
View More
Cystic Fibrosis (CF) KOL Interview ...
March 2, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Datamonitor Healthcare CV&Met Disea...
February 11, 2026
Datamonitor Healthcare Infectious D...
February 11, 2026
Datamonitor Healthcare CV&Met: Syst...
February 11, 2026
Datamonitor Healthcare Oncology: NH...
February 11, 2026
Datamonitor Healthcare Oncology: Ga...
February 11, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 10, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 9, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Dealmaking Quarterly Statistics, Q4...
February 5, 2026
Financing Quarterly Statistics, Q4 ...
February 5, 2026
Datamonitor Healthcare I&I: Axial S...
February 4, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/1/26 | Sanofi (SNY) | Dupixent for Aspergillosis | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/1/26 | Sanofi (SNY) | Dupixent for Asthma | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/24/26 | Abcuro | Ulviprubart for Sporadic Inclusion Body Myositis (sIBM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/23/26 | BioMarin (BMRN) | Roctavian for Hemophilia A | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/23/26 | BioMarin (BMRN) | Roctavian for Hemophilia A | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |